Feb 6 (Reuters) - U.S. drugstore chain Walgreens Boots Alliance WBA.O said on Thursday it has sold more shares in drug distributor Cencora COR.N for proceeds of about $300 million.
The company said that it now owns a 6% stake in Cencora, trimming it down from 10% it previously held. It sold Cencora shares worth $1.1 billion in August.
Walgreens has sold about $265 million worth of shares and Cencora has agreed to repurchase about $50 million worth of shares, the company said in a statement.
Proceeds from the share sale will be used primarily for debt pay down and general corporate purposes, as Walgreens continues to build out a more capital-efficient health services strategy rooted in its retail pharmacy footprint.
The pharmacy chain reiterated that the sale has no impact to the long-term partnership between the two companies.
(Reporting by Pretish M J in Bengaluru; Editing by Rashmi Aich)
((PretishMJ@thomsonreuters.com; +91 8056974974;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。